FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

Clinical trial NCT05312567 · COMPLETED

Trial details

NCT number: NCT05312567
Sponsor: Fervent Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vasomotor Symptoms Menopause

Start date: 2021-03-24
Primary completion: 2023-04-05
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.